Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,340.09
1,197.17
1,176.26
888.67
679.86
467.59
332.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,340.09
1,197.17
1,176.26
888.67
679.86
467.59
332.24
Raw Material Cost
432.39
353.55
294.45
237.45
161.25
104.65
75.87
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
209.41
228.06
182.39
182.55
127.32
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.32
2.03
2.04
2.33
1.93
0.11
0.00
Selling and Distribution Expenses
263.13
233.68
177.45
142.20
99.27
77.89
69.90
Other Expenses
-15.03
-14.45
-1.73
-5.18
-3.10
6.87
4.48
Total Expenditure (Excl Depreciation)
756.92
672.85
638.99
512.70
358.73
251.38
190.55
Operating Profit (PBDIT) excl Other Income
583.2
524.3
537.3
376
321.1
216.20000000000002
141.7
Other Income
79.84
79.82
46.06
52.26
45.18
35.65
25.81
Operating Profit (PBDIT)
745.15
657.50
624.30
469.52
390.16
265.28
175.10
Interest
2.32
2.03
2.04
2.33
1.93
0.11
0.00
Exceptional Items
0.37
56.46
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
907.70
843.62
881.81
651.22
518.61
362.94
256.37
Depreciation
89.71
60.66
46.22
44.00
26.57
15.61
10.77
Profit Before Tax
653.49
651.26
576.04
423.19
361.66
249.55
164.34
Tax
98.83
159.45
85.05
61.84
48.15
34.94
22.58
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
563.33
502.10
492.43
356.88
315.86
214.61
141.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
563.33
502.10
492.43
356.88
315.86
214.61
141.76
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-8.67
-9.35
-5.21
-4.83
-2.34
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
554.66
492.75
487.22
352.05
313.51
214.61
141.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,075.34
3,791.84
3,843.82
1,718.67
1,494.29
1,233.97
1,065.97
Earnings per share (EPS)
4.65
4.12
4.0
3.33
2.95
2.0
1.32
Diluted Earnings per share
4.65
4.12
4.0
3.33
2.95
2.0
1.32
Operating Profit Margin (Excl OI)
42.95%
43.19%
45.23%
42.0%
46.83%
45.77%
41.7%
Gross Profit Margin
55.46%
59.47%
52.9%
52.57%
57.1%
56.71%
52.7%
PAT Margin
42.04%
41.94%
41.86%
40.16%
46.46%
45.9%
42.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 11.94% vs 1.78% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 12.58% vs 1.13% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 15.16% vs -0.09% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 15.00% vs 0.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Shanghai MicroPort Endovascular MedTech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,340.09
0
1,340.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,340.09
0
1,340.09
Raw Material Cost
432.39
0
432.39
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
209.41
0
209.41
Power Cost
0
0
0.00
Manufacturing Expenses
2.32
0
2.32
Selling and Distribution Expenses
263.13
0
263.13
Other Expenses
-15.03
0.00
-15.03
Total Expenditure (Excl Depreciation)
756.92
0
756.92
Operating Profit (PBDIT) excl Other Income
583.17
0.00
583.17
Other Income
79.84
0
79.84
Operating Profit (PBDIT)
745.15
0
745.15
Interest
2.32
0
2.32
Exceptional Items
0.37
0
0.37
Gross Profit (PBDT)
907.70
0
907.70
Depreciation
89.71
0
89.71
Profit Before Tax
653.49
0
653.49
Tax
98.83
0
98.83
Provisions and contingencies
0
0
0.00
Profit After Tax
563.33
0
563.33
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
563.33
0
563.33
Share in Profit of Associates
0
0
0.00
Minority Interest
-8.67
0
-8.67
Other related items
0.00
0.00
0.00
Consolidated Net Profit
554.66
0
554.66
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,075.34
0
4,075.34
Earnings per share (EPS)
4.65
0
4.65
Diluted Earnings per share
4.65
0
4.65
Operating Profit Margin (Excl OI)
42.95%
0%
0.00
42.95%
Gross Profit Margin
55.46%
0%
0.00
55.46%
PAT Margin
42.04%
0%
0.00
42.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 134.01 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 11.94% vs 1.78% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 55.47 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 12.58% vs 1.13% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 66.53 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 15.16% vs -0.09% in Dec 2024
Annual - Interest
Interest 0.23 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 15.00% vs 0.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 42.95%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






